World's Best Scientists 2026 revealed!
Filomeen Haerynck

Filomeen Haerynck

D-Index & Metrics

Immunology

D-Index
47
Citations
13594
World Ranking
4470
National Ranking
74

Filomeen Haerynck publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Filomeen Haerynck sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 223 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Filomeen Haerynck D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Filomeen Haerynck sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Filomeen Haerynck is affiliated with Ghent University in Belgium and has a research focus spanning medicine, immunology, microbiology, biochemistry, genetics, and molecular biology. Their work notably intersects several subfields, including immunology, infectious diseases, molecular biology, genetics, and surgery.

The scientist has contributed to the understanding of immunodeficiency and autoimmune disorders, SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, Kawasaki disease and coronary complications, interferon and immune responses, diabetes and associated disorders, as well as respiratory viral infections research.

Haerynck's recent published papers include:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, 2020, Science
  • Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths, 2021, Science Immunology
  • Multisystem inflammatory syndrome in children related to COVID-19: a systematic review, 2021, European Journal of Pediatrics
  • Human genetic and immunological determinants of critical COVID-19 pneumonia, 2022, Nature

Frequent co-authors with significant collaboration counts include Simon J. Tavernier, Levi Hoste, Paul Bastard, Isabelle Meyts, and Tayfun Özçelık.

Their work is often published in journals such as The Journal of Experimental Medicine, Frontiers in Immunology, Journal of Allergy and Clinical Immunology, bioRxiv (Cold Spring Harbor Laboratory), and Journal of Clinical Immunology.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • Multisystem inflammatory syndrome in children related to COVID-19: a systematic review.

    Levi Hoste;Ruben Van Paemel;Filomeen Haerynck

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

  • Genes associated with common variable immunodeficiency: one diagnosis to rule them all?

    Delfien J A Bogaert;Melissa Dullaers;Bart N Lambrecht;Karim Y Vermaelen

  • Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

    Federica Barzaghi;Laura Cristina Amaya Hernandez;Benedicte Neven;Silvia Ricci

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

    Unknown

  • Familial Mediterranean Fever Mutations Lift the Obligatory Requirement for Microtubules in Pyrin Inflammasome Activation

    Hanne Van Gorp;Pedro Henrique Viana Saavedra;Nathalia Moraes de Vasconcelos;Nina Van Opdenbosch

  • Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score

    Victoria Katharina Tesch;Hassan Abolhassani;Hassan Abolhassani;Bella Shadur;Bella Shadur;Joachim Zobel

  • Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation

    Aude Magerus-Chatinet;Bénédicte Neven;Marie Claude Stolzenberg;Cécile Daussy

  • Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations.

    Julian Thalhammer;Gerhard Kindle;Alexandra Nieters;Stephan Rusch

  • Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    Unknown

  • SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Vanessa Sancho-Shimizu;Petter Brodin;Aurélie Cobat;Aurélie Cobat;Aurélie Cobat;Catherine M Biggs

  • Structural Activation of Pro-inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1.

    Yehudi Bloch;Laura Bouchareychas;Laura Bouchareychas;Romain Merceron;Katarzyna Składanowska

  • Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

    Scott B Drutman;Filomeen Haerynck;Franklin L Zhong;David Hum

  • X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world

    Zeinab A. El-Sayed;Irina Abramova;Juan Carlos Aldave;Waleed Al-Herz

  • Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

    Béziat;Tavernier Sj;Chen Yh;Ma Cs

  • Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.

    Ana Karina Alves de Medeiros;Evelyn Lodewick;Delfien J A Bogaert;Filomeen Haerynck

  • TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

    Levi Hoste;Lisa Roels;Leslie Naesens;Victor Bosteels

  • Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

    Jozefien Declercq;Karel F A Van Damme;Elisabeth De Leeuw;Bastiaan Maes

Frequent Co-Authors

Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Laurent Abel
Laurent Abel Université Paris Cité
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Elfride De Baere
Elfride De Baere Ghent University
Emmanuelle Jouanguy
Emmanuelle Jouanguy Necker-Enfants Malades Hospital
Aurélie Cobat
Aurélie Cobat Grenoble Alpes University
Aurora Pujol
Aurora Pujol Institut d'Investigació Biomédica de Bellvitge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can provide valuable career options. Programs like Licensed Practical Nurse (LPN) pathways offer a practical entry into healthcare with fewer barriers. If you are seeking programs with less competitive admissions, check out the easiest lpn programs to get into.

Nursing roles, especially Nurse Practitioners, often specialize in areas like immunological disorders or mental health. For professionals aiming to advance quickly, understanding which nurse practitioner program is easiest can help streamline the education process without sacrificing quality.

Mental health is closely linked to immunology through inflammation and neurological pathways. If you want to specialize further, consider the best online psychiatric mental health nurse practitioner programs that provide reliable clinical placements essential for hands-on experience.

Cost is also a significant factor when selecting an advanced degree, especially in specialized fields. For budget-conscious students, exploring the cheapest pmhnp programs can offer financial relief while pursuing a meaningful healthcare career.

Best Scientists Citing Filomeen Haerynck

Trending Scientists

Recently Published Articles